SOPHiA GENETICS S.A. (SOPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
Rue du Centre 172
Rolle, VD 1025
Switzerland
Phone
41 21 694 10 60
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
415
First IPO Date
July 23, 2021
| Name | Title | Pay | Year Born |
| Ross Jordan Muken | CEO & Director | 0 | 1980 |
| Jurgi Camblong | Co-Founder & Executive Chairman | 1.21M | 1978 |
| Zhenyu Xu | Executive Vice President & Chief Scientific Officer | 0 | 1983 |
| Abhimanyu Verma | EVP & Chief Technology Officer | 0 | N/A |
| Daan van Well | Executive VP and Chief Legal & Compliance Officer | 0 | 1975 |
| Philippe Menu | Executive Vice President, Chief Medical Officer & Chief Product Officer | 0 | 1982 |
| Kellen Sanger | Head of Strategy and Investor Relations | 0 | N/A |
| George A. Cardoza | Executive Vice President & Chief Financial Officer | 0 | 1962 |
| Kevin Puylaert | SVP & Chief Sales Officer | 0 | N/A |
| Manuela Da Silva Valente | Executive Vice President & Chief People Officer | 0 | 1971 |
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.